Tuesday, November 22, 2016

Shockwave Medical Gets $45M In Series C

Fremont-based Shockwave Medical, which is developing treatments for calcified cardiovascular disease, has raised $45M in a Series C funding round. The funding was led by Sectoral Asset Management, and also included T. Rowe Price Associates, Sofinnova Partners, Venrock, RA Capital, Deerfield, Ally Bridge Group and others. Shockwave Medical's CEO and co-founder is Daniel Hawkins. The company said the funding will be used to advance its balloon catheter platform into new therapeutics areas, and to expand commercialization of its technology. More information »